Figure 2
Figure 2. Steroid treatment before and after LD-rituximab in AIHA patients. (A) Average locally weighted smoothed (lowess) of 15 AIHA patients relapsed after standard steroid treatment. (B-G) Typical examples of prednisone administration in 6 AIHA patients. (B-C) WAIHA responders to LD-rituximab. (D-E) WAIHA responders relapsed at month +13 and +16 after LD-rituximab. (F) CHD responder to LD-rituximab. (G) CHD nonresponder relapsed at month +10 after LD-rituximab.

Steroid treatment before and after LD-rituximab in AIHA patients. (A) Average locally weighted smoothed (lowess) of 15 AIHA patients relapsed after standard steroid treatment. (B-G) Typical examples of prednisone administration in 6 AIHA patients. (B-C) WAIHA responders to LD-rituximab. (D-E) WAIHA responders relapsed at month +13 and +16 after LD-rituximab. (F) CHD responder to LD-rituximab. (G) CHD nonresponder relapsed at month +10 after LD-rituximab.

Close Modal

or Create an Account

Close Modal
Close Modal